CompletedNot Applicable

EURAD MRI Classification of US Indeterminate Adnexa Lesions

United States1,340 participantsStarted 2014-02

Plain-language summary

This research is targeting patients with sonographically indeterminate adnexal mass that are being referred for clinical MR imaging. Investigators from the UW will be contributing coded MR images and associated health information (US results, laboratory/pathology results) to the EURAD trial. In addition, outcomes data on each patient will be sent at month 24 of the research.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 years of age or older * With indeterminate ultrasonographic adnexal mass Exclusion Criteria: * Patients under 18 years of age

What they're measuring

Reproducibility of the ADNEX MR scoring system between centers

Timeframe: 24 months

Trial details

NCT IDNCT02962596

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-10-14

View on ClinicalTrials.gov More Ovarian Tumor trials